Effect of Homoeopathic medicines in Rheumatoid Arthritis
Phase 3
- Conditions
- Health Condition 1: M05- Rheumatoid arthritis with rheumatoid factor
- Registration Number
- CTRI/2019/11/021895
- Lead Sponsor
- Hafsa Muhammed
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cases with Anti CCP above 20 IU/ml
Cases fulfilling the diagnostic criteria of rheumatoid arthritis
Exclusion Criteria
Patients with any known serious co-morbities of Rheumatoid Arthritis
Patients on NSAIDs/DMARDs
Rheumatoid Arthritis associated with complicated systemic disease
Pregnant women and lactating mothers
Immuno compromised patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method symptomatic improvement in RA patients with reduction in anti CCP and RA values.Timepoint: 1 year followup
- Secondary Outcome Measures
Name Time Method symptomatic improvement in patients using the RASS (Rheumatoid Arthritis Severity Scale)Timepoint: 1 year followup